In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

How to select long-term dual antiplatelet therapy? Benefit and harm balance

ESC webinar on general cardiology

Add to calendar31/05/201818:00 31/05/201819:00 Europe/Paris How to select long-term dual antiplatelet therapy? Benefit and harm balance

Join Dr. Marco Valgimigli, Dr. Willem DeWilde and Prof. Hector Bueno

European Society of Cardiology contact@escardio.org DD/MM/YYYY
Acute Cardiac Care
Online
event

Summary

Join Dr. Marco Valgimigli, Dr. Willem DeWilde and Prof. Hector Bueno



Register Now

New: measure your knowledge gain with the pre and post evaluation.

Faculty

Speakers

valgimigli-marco-2015.jpgDoctor Marco Valgimigli, FESC
Inselspital
Cardiology
Switzerland

Dewilde-willem-2017.jpg

Doctor Willem DeWilde
Amphia Hospital
Netherlands

Host

bueno_hector-2016.jpgProfessor Hector Bueno, FESC
Cardiology
Centro Nacional de Investigaciones Cardiovasc
Spain

Session information

This webinar addresses general cardiologists but also cardiologists wishing to update their scientific knowledge on the topic.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).